Epidemiosurveillance of antimicrobial compound resistance of Staphylococcus intermedium clinical isolates from canine pyodermas.

In a retrospective study, 131 Staphylococcus intermedius strains isolated from apparently healthy dogs, and 187 Staphylococcus intermedius strains isolated from dog pyodermas in the clinical microbiology laboratory at the National Veterinary School in Nantes, during three successive periods: 1986-87, 1992-93 and 1995-96, were investigated and compared for their antimicrobial susceptibility. Results indicated that 60% to 65% of the strains were susceptible to Chloramphenicol and Doxycyclin, 65% to 80% of the strains were susceptible to macrolides (Erythromycin, Lincomycin and Clindamycin) and to Trimethoprim/Sulfonamide association. More than 95% of the strains were susceptible to three betalactamins tested: Oxacillin, Amoxycillin/Clavulanic acid, Cephalexin, to Gentamicin, to Fucidic Acid and to two quinolones: Enrofloxacin and Marbofloxacin. This last group is made up of choice antibacterials for the treatment of dog pyoderma. Many different resistance patterns were observed in each period with no really predominant profile, because of low plasmidic vs chromosomal balance of the genetic basis of antibacterial resistance in Staphylococcus intermedius. However, the proportion of multiresistant (> or = 3 drugs) strains increased from 10.8% in the first period, to 28% in the third period. This increased frequency of resistance suggests strongly that, as in Staphylococcus aureus human infections, the prescription of antibiotic compounds increases the prevalence of resistant strains.

[Brucellosis among occupationally exposed people: evaluation of immunological tests after vaccination]. / Brucellose en milieu professionnel exposé: évaluation des tests immunologiques après vaccination.

For the evaluation of immunological tests during an epidemiological survey and of vaccination with the PI brucellin vaccine, in an occupationally exposed environment, a sample group of 354 subjects was studied. The vaccinal strategy was based on the outcome of a skin test for hypersensitivity: the PS brucellin test. In this framework, the serological status and evolution of individuals with positive or negative reactions to this test were analysed. Sera were studied using the buffered antigen test, indirect fluorescence immunoassay and Wright's agglutination test, as well as by PACIA and ELISA techniques with assay of IgG, IgA and IgM antibodies. The PS test, which was pivotal in this study, was compared with the lymphoblastic transformation test. One prominent aspect of this evaluation was the establishment of conventional prognostic indices for the PS and serology. The PS is definitely shown to be a convenient, reliable tool for screening. Although it does not generate sensitivity it may modify the serological status of both positive and negative individuals.

Immunomodulatory properties of a strain of Mycobacterium chelonae--II. Qualitative and quantitative stimulation of mouse splenocytes by Mycobacterium chelonae.

Intraperitoneal [i.p.] and subcutaneous [s.c.] administration to BALB/C mice with a single dose of 5 mg/kg body weight (wet weight) of live Mycobacterium chelonae (Mch) augmented splenocyte blastogenesis. Similar increases in splenocyte blastogenesis manifested during a single oral administration to mice with 100 mg/kg body weight (wet weight) of this Mycobacterium. When splenocytes issued from these mice are activated by mitogens, a highly significant enhancement of lymphoblastic transformation was observed. On the other hand, multiple oral administrations with 50 mg/kg body weight (wet weight) to Mch/dose did not manifest statistically significant differences in splenocyte blastogenesis as compared to controls. Meanwhile, a highly increased transformation of splenocytes, issued from such mice, is observed in response to lectins and to the mitogenic effect of this microorganism. Splenocyte counts have shown 44.5, 37.6, and 23.2% increases in response to i.p., s.c. and multiple oral administration of this bacterium, respectively, as compared to solvent controls. Repeated s.c. administration of this mycobacterium manifested short lived and weak syndromes of anaphylactic shock during and immediately after the second inoculation of Mch. This phenomenon is not observed during repeated intraperitoneal and oral administrations. In conclusion, parenteral (i.p. and s.c.) and oral administration of Mch stimulates the immune system of mice. This effect is characterised by increased in vivo cell multiplication and by enhanced ex vivo DNA synthesis of murine splenocytes. The need of further studies is eminent to elucidate classes of immunocompetent cells involved in this phenomenon.

Immunomodulatory properties of a strain of Mycobacterium chelonae. I. Mouse lymphocyte responses in vitro.

Immunomodulatory properties of a strain of live Mycobacterium chelonae (Mch) was investigated in an in vitro lymphocyte transformation system. Murine splenocyte activation by this bacterium was characterized by polyclonal lymphoproliferative responses in a dose dependent fashion. Optimal doses ranging from 20 to 80 micrograms of Mch (wet weight) per ml of cell suspension induced a very significant mitogenic effect. Higher doses (100 micrograms) of Mch manifested a decreased rate of tritiated thymidine ([3H] TdR) uptake whereas responsiveness of splenic lymphocytes to lower doses (0.156 microgram) was not modified. Contrary to the splenocyte responses activation of murine thymocytes by this mycobacterium is characterised by a decreased proliferation as compared to the background count of unstimulated cells. Simultaneous addition of Mch with optimal doses of Concanavalin A (Con A) and Phytohemaglutinin (PHA) potentiated polyclonal mitogenic responses of murine splenocytes to these two lectins. However, proliferation of these lymphocytes to Lypopolysaccharide (LPS) induction was not modified. BALB/C and DBA/2 spenocytes were found to be more responsive to stimulation by this Mycobacterium as compared to those of C3H/Ou and to a lesser degree to those of C57BL/6 mice.

Modulation of mesangial cell migration by extracellular matrix components. Inhibition by heparinlike glycosaminoglycans.

Extension of mesangial cells (MC) into the pericapillary space is a pathologic response seen in several forms of glomerulonephritis. This process may involve both cytoplasmic extension by MC and actual cellular migration. For investigation of whether extracellular matrix factors could modulate this process, the migratory responses of rat MC were quantitatively examined using a cell culture model. Denuding ("wounding") a portion of a confluent culture of MC was followed by migration of mesangial cells into the denuded area. The expected proliferative response to this treatment was blocked by irradiation. The migratory response began within 8 hours of wounding and continued for at least 80 hours. The MC migratory response was specifically inhibited in a dose-dependent and reversible manner by heparin and heparinlike glycosaminoglycans (GAGs). Chondroitin sulfates and hyaluronic acid did not significantly inhibit MC migration. Glomerular basement membrane heparinlike GAGs may normally prevent MC extension into the pericapillary space. Changes in the density or composition of these substances during glomerular inflammatory processes could permit the development of MC pericapillary extensions and thereby lead to further alterations in basement membrane integrity.

Production and control of specificity of a goat anti-bovine thymocytes antiserum.

The identification and the numeration of the lymphocytes in cattle is realized essentially by revealing the membranary properties of these cells: receptors for some lectins (i.e. peanut agglutinin or phytohemagglutinin), receptors for sheep red blood cells (SRBC), surface-specific antigens concerning T-lymphocytes and surface immunoglobulins concerning B-lymphocytes. The technique of the production in the goat of a specific anti-bovine T-lymphocyte antiserum (GABTA) is described. The GABTA shows a specific cytotoxic activity on 55% of the peripheral blood lymphocytes and more than 95% of the thymocytes. It inhibits, at 90%, the formation of the rosetting with SRBC. This reagent allows identification and a common and quick numeration of the T-lymphocytes in cattle.

Exploration of the cellular mediated immunity by the blastogenesis test during chronic brucellosis in human.

The diagnosis of the chronic, human brucellosis is frequently difficult and usually needs experimental methods. This paper describes a lymphocyte stimulation test with a Brucella antigen and the results of this test concerning 45 brucellic or not brucellic patients. It is concluded that this test is interesting, especially for the chronic and sero-negative Brucellosis diagnosis.

[Immunocompetence of newborn calves: evaluation of the proliferative response of lymphocytes in vitro to 3 nonspecific mitogens (concanavalin A, phytohemagglutinin, pokeweed mitogen) during the 1st 3 months of life]. / Immunocompétence du veau nouveau-né: évaluation de la résponse lymphocytaire proliférative in vitro à trois mitogenès non spécifiques (concanavaline A, phytohémagglutinine, pokeweed mitogen) au cours des trois premiers mois de vie.

A micromethod technique was used to evaluate in vitro sensitivity of the peripheric bovine lymphocytes obtained from a newly born calf, up to 3 months of age to different non-specific mitogens: Phytohemagglutinin (PHA) Concanavaline A (Con A) and Pokeweed Mitogen (PWM). The results obtained show that the calf lymphocytes respond to the 3 mitogens by a considerable cellular proliferation. The blastogenic response was found at various levels during the first 3 months of life, and appeared to stabilize at levels similar to the adult bovine. Highly sensitive variations were noted in the lymphocyte reactivity, notably with PHA and Con A. These results seem to indicate the existence of periods of T cell immunodeficiency, not only during the first few days after birth, but throughout the first months of the calves' life. It may also be indicative of the interest of immunostimulant therapy during this period, which needs further investigation.